References
- ChlebowskiRTChenZAndersonGLEthnicity and breast cancer: factors influencing differences in incidence and outcomeJ Natl Cancer Inst200597643944815770008
- TehardBClavel-ChapelonFSeveral anthropometric measurements and breast cancer risk: results of the E3N cohort studyInt J Obes (Lond)200630115616316231021
- van den BrandtPASpiegelmanDYaunSSPooled analysis of prospective cohort studies on height, weight, and breast cancer riskAm J Epidemiol2000152651452710997541
- MorimotoLMWhiteEChenZObesity, body size, and risk of postmenopausal breast cancer: the Women’s Health Initiative (United States)Cancer Causes Control200213874175112420953
- MathewAGajalakshmiVRajanBAnthropometric factors and breast cancer risk among urban and rural women in South India: a multicentric case-control studyBr J Cancer200899120721318542077
- ChowLWLuiKLChanJCAssociation between body mass index and risk of formation of breast cancer in Chinese womenAsian J Surg200528317918416024311
- BerclazGLiSPriceKNfor International Breast Cancer Study GroupBody mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceAnn Oncol200415687588415151943
- WhitemanMKHillisSDCurtisKMMcDonaldJAWingoPAMarchbanksPABody mass and mortality after breast cancer diagnosisCancer Epidemiol Biomarkers Prev20051482009201416103453
- NicholsHBTrentham-DietzAEganKMBody mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortalityCancer Epidemiol Biomarkers Prev20091851403140919366908
- ClevelandRJEngSMAbrahamsonPEWeight gain prior to diagnosis and survival from breast cancerCancer Epidemiol Biomarkers Prev20071691803181117855698
- LoiSMilneRLFriedlanderMLObesity and outcomes in premenopausal and postmenopausal breast cancerCancer Epidemiol Biomarkers Prev20051471686169116030102
- DemirkanBAlacaciogluAYilmazURelation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinomaJpn J Clin Oncol200737425626517553816
- MoonHGHanWNohDYUnderweight and breast cancer recurrence and death: a report from the Korean Breast Cancer SocietyJ Clin Oncol200927355899590519805676
- SuzukiRRylander-RudqvistTYeWSajiSWolkABody weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort studyInt J Cancer200611971683168916646051
- AhnJSchatzkinALaceyJVJrAdiposity, adult weight change, and postmenopausal breast cancer riskArch Intern Med2007167192091210217954804
- EngerSMRossRKPaganini-HillACarpenterCLBernsteinLBody size, physical activity, and breast cancer hormone receptor status: results from two case-control studiesCancer Epidemiol Biomarkers Prev20009768168710919738
- PhippsAIMaloneKEPorterPLDalingJRLiCIBody size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal womenCancer Epidemiol Biomarkers Prev20081782078208618664548
- SteadLALashTLSobierajJETriple-negative breast cancers are increased in black women regardless of age or body mass indexBreast Cancer Res2009112R1819320967
- MillikanRCNewmanBTseCKEpidemiology of basal-like breast cancerBreast Cancer Res Treat2008109112313917578664
- CarlsonRWMoenchSJHammondMEfor NNCN HER2 Testing in Breast Cancer Task ForceHER2 testing in breast cancer: NCCN Task Force report and recommendationsJ Natl Compr Canc Netw20064Suppl 3S1S22 quiz S23–S24.
- WolffACHammondMESchwartzJNfor American Society of Clinical Oncology, College of American PathologistsAmerican Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancerJ Clin Oncol200725111814517159189
- WHO Expert ConsultationAppropriate body-mass index for Asian populations and its implications for policy and intervention strategiesLancet2004363940315716314726171
- GoldhirschAWoodWCCoatesASGelberRDThürlimannBSennHJfor Panel membersStrategies for subtypes – dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Ann Oncol20112281736174721709140
- BeggCBZhangZFStatistical analysis of molecular epidemiology studies employing case-seriesCancer Epidemiol Biomarkers Prev1994321731758049640
- EmausAVeierødMBTretliSMetabolic profile, physical activity, and mortality in breast cancer patientsBreast Cancer Res Treat2010121365166019882245
- BerstadPCoatesRJBernsteinLA case-control study of body mass index and breast cancer risk in white and African-American womenCancer Epidemiol Biomarkers Prev20101961532154420501755
- CaanBJKwanMLHartzellGPre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancerCancer Causes Control200819101319132818752034
- CareyLAPerouCMLivasyCARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA2006295212492250216757721
- YangXRShermanMERimmDLDifferences in risk factors for breast cancer molecular subtypes in a population-based studyCancer Epidemiol Biomarkers Prev200716343944317372238
- SuYZhengYZhengWDistinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort studyBMC Cancer20111129221749714
- XingPLiJJinFA case-control study of reproductive factors associated with subtypes of breast cancer in Northeast ChinaMed Oncol201027392693119771534
- VoducKDCheangMCTyldesleySGelmonKNielsenTOKenneckeHBreast cancer subtypes and the risk of local and regional relapseJ Clin Oncol201028101684169120194857